If your doctor suggests medication to trigger ovulation because of PCOS, two names come up most often: letrozole and clomiphene citrate (the older brand many people know as Clomid). Both are tablets taken by mouth for a few days early in the cycle, and both aim to do the same thing, namely coax the ovaries into releasing an egg so the chance of pregnancy rises. But large studies over the past decade have changed how doctors choose between them, and that shift favours letrozole for women with PCOS.

This article explains the real difference between the two, what the evidence shows, and what you should understand before you talk it through with a specialist at your PCOS fertility clinic.

Two drugs, two different ways of working

Clomiphene and letrozole both trick the brain into sensing that oestrogen is low, so the brain sends a signal (FSH) to grow an egg follicle. The difference lies in how they do it.

Clomiphene blocks oestrogen receptors. That blockade is long-lasting and body-wide, including on the womb lining (endometrium) and cervical mucus. This is why some women who do ovulate on Clomid still struggle to conceive, because the lining can become thin and the mucus thick, making it harder for sperm.

Letrozole belongs to a group called aromatase inhibitors. It lowers oestrogen production only briefly, and the drug clears from the body quickly. As a result the brain is stimulated to grow an egg, but the womb lining usually stays healthier and more suitable for implantation. There is another subtle difference: clomiphene tends to grow several follicles at once because its blockade lingers, while letrozole more often produces a single dominant follicle. This is one reason the twin-pregnancy risk is lower with letrozole, and why the studies lean towards it.

What the major studies show

The most important evidence comes from a large randomised trial published in the New England Journal of Medicine in 2014 (known as PPCOS II, led by Richard Legro). It enrolled 750 women with PCOS who wanted to conceive and compared letrozole with clomiphene head to head.

The result clearly favoured letrozole. The live-birth rate was about 27.5 percent with letrozole versus 19.1 percent with clomiphene. The cumulative ovulation rate was also higher, around 62 percent versus 48 percent. That means more women ovulated, and crucially, more took home a baby.

A common worry is the risk of twins. Here the news is reassuring, because the trial showed no meaningful difference in twin pregnancy rates between the two groups, with twin rates actually fairly low on letrozole (around 3 percent versus 7 percent with clomiphene). Miscarriage rates also did not differ significantly between the two groups. The risk of congenital anomalies (birth defects) likewise did not differ significantly between them, a point people often ask about because letrozole was originally a breast-cancer drug. The early concern came from a brief 2005 report, but larger follow-up studies did not confirm it.

Who benefits most from letrozole

The evidence shows the advantage of letrozole is clearest in women with PCOS who are overweight or obese. In this group clomiphene tends to work less well, while letrozole delivers better ovulation and live-birth rates. Since weight is one of the heaviest PCOS burdens in Malaysia, this is an important practical point.

Letrozole is also often tried in women who have already failed to ovulate on clomiphene (a situation called “clomiphene resistance”). Some of these women eventually ovulate once they switch to letrozole, so failure with one drug does not mean a dead end. On the other hand, some women are lean with near-regular cycles, and for them both drugs can work, so the choice can rest on cost, availability, and comfort.

Why letrozole is now the first-line choice

On the strength of evidence like this, the 2023 international PCOS guideline (endorsed by the Endocrine Society and major specialist bodies) recommends letrozole as the first-line medication for PCOS-related infertility, provided there are no other infertility factors. Clomiphene is not discarded, it now sits as a second-line option, usually used with metformin, or when letrozole is unsuitable or does not work. Letrozole has also been added to the WHO Essential Medicines List for ovulation induction, a recognition that it is both effective and affordable.

Metformin is sometimes added, especially if there are clear signs of insulin resistance. For some women a drug combination can improve the chance of ovulation compared with clomiphene alone, but the decision to add metformin rests on your doctor’s assessment, not something you should start yourself.

One important thing to understand, in almost every country including Malaysia, letrozole is used “off-label” for fertility. This means its licence was originally for breast cancer, not for triggering ovulation. Off-label use is a normal and accepted part of medicine when strong evidence backs it, but it helps to know this status so you are not surprised when you read the drug leaflet.

The doses studies used

This section is for understanding only, not a prescription. Your actual dose must be set by your doctor based on your body and how your ovaries respond.

In most studies, letrozole was started at 2.5 mg a day for five days, usually beginning on day three to five of the cycle. If ovulation does not happen at that dose, the doctor may step the dose up gradually (for example to 5 mg, and in studies as high as 7.5 mg a day). Clomiphene is typically started at 50 mg a day for five days early in the cycle, and can be raised if needed. For both, the doctor usually monitors with an ultrasound scan or tests to confirm the egg is maturing and to avoid too many follicles. For women who are unmarried or have never had intercourse, the abdominal (transabdominal) ultrasound is the usual monitoring method in Malaysia, and it is sufficient.

How a treatment cycle runs

Understanding the flow of a cycle helps ease the worry. Treatment usually starts after a period arrives (sometimes brought on with medication if a period has been absent for a long time). You take the tablets for five days, then your doctor may schedule an ultrasound scan around day ten to fourteen to see whether a follicle is growing. When a follicle is mature enough, the couple is advised to try around the fertile window, or in some cases a trigger injection is given.

An unsuccessful cycle is not a sign that treatment has failed. Doctors usually try several cycles (up to five or six) before reassessing. If ovulation happens but pregnancy has not yet, that is a good sign the drug is working, and the strategy may continue. If ovulation does not happen at all, the dose or drug may be changed. Patience with this process matters, because the cumulative chance rises with each ovulatory cycle.

Safety and side effects

No medication is free of side effects. Clomiphene more often causes hot flushes, mood changes, and occasionally blurred vision. The thinning effect on the womb lining is also more pronounced with it.

Letrozole generally has milder side effects, but some women report fatigue, dizziness, or headache. Neither drug can be taken during pregnancy, so cycle monitoring matters. If you have liver problems, a history of blood clots, or take other medicines, tell your doctor because this affects the choice and dose.

It is also worth remembering that fertility medication only solves one branch of the problem, namely ovulation. PCOS carries long-term risks such as type 2 diabetes and heart disease, so weight care, nutrition, and health screening stay relevant even while you are trying to conceive. If you were recently diagnosed and are unsure of the next step, the guide for the newly diagnosed can help you order your priorities.

Questions to bring to your doctor

A structured conversation makes a clinic visit more useful. Some questions worth asking:

  • Based on my situation (weight, age, hormone test results), do you recommend letrozole or clomiphene, and why?
  • Do I need metformin or any additional medication alongside it?
  • How will you monitor whether I am ovulating, and when should I come in for a scan?
  • How many cycles will we try before we reassess the plan?
  • What signs should I report straight away (for example severe abdominal pain or extreme bloating)?

Bringing a record of your menstrual cycles and a list of your current medicines also helps the doctor decide.

What this means for you in Malaysia

The usual pathway starts at a KKM Klinik Kesihatan (around RM1 for citizens), where a medical officer can begin basic investigations and refer you to a hospital O&G clinic for ovulation treatment. Specialist follow-up at a government hospital is around RM5. At private clinics the cost is higher and varies by centre, so it helps to ask for an estimate before you start. Drugs like letrozole and clomiphene are generally inexpensive compared with advanced fertility treatment.

To understand whether you are actually ovulating before and after the medication, read how to track ovulation in PCOS and the use of ovulation test strips (OPKs), which are sometimes less reliable for women with PCOS. If several medicated cycles do not succeed, your doctor may discuss next steps such as gonadotropins or IVF for PCOS in Malaysia. For a full picture of the condition, start with what PCOS is.

The line for seeing a doctor is simple, if you have been trying to conceive for more than six to twelve months without success, your periods are very irregular, or you want to plan a pregnancy with PCOS, talk to a gynaecologist. The choice between letrozole and clomiphene is not something you decide alone, it is a shared decision with your doctor based on your body, age, and priorities.